Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data.
Cancer Manag Res. 2023 Oct 3;15:1085-1096. doi: 10.2147/CMAR.S412270. eCollection 2023.
Cancer Manag Res. 2023.
PMID: 37809035
Free PMC article.
The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.
Caliskan Yildirim E, Atag E, Coban E, Umit Unal O, Celebi A, Keser M, Uzun M, Keskinkilic M, Tanrikulu Simsek E, Sari M, Yavuzsen T.
Caliskan Yildirim E, et al.
Breast. 2023 Aug;70:56-62. doi: 10.1016/j.breast.2023.06.006. Epub 2023 Jun 14.
Breast. 2023.
PMID: 37343321
Free PMC article.
Item in Clipboard
What Is Your Choice for Androgen Deprivation Therapy in Metastatic Prostate Carcinoma: Surgical or Medical?
Semiz HS, Kisa E, Caliskan Yildirim E, Atag E, Arayici ME, Muezzinoglu T, Karaoglu A.
Semiz HS, et al. Among authors: caliskan yildirim e.
Turk J Urol. 2022 Jul;48(4):287-293. doi: 10.5152/TJU.2022.22076.
Turk J Urol. 2022.
PMID: 35913444
Free PMC article.
Item in Clipboard
KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer.
Ergun Y, Acikgoz Y, Bal O, Ucar G, Dirikoc M, Caliskan Yildirim E, Akdeniz N, Uncu D.
Ergun Y, et al. Among authors: caliskan yildirim e.
Expert Rev Mol Diagn. 2019 Dec;19(12):1131-1140. doi: 10.1080/14737159.2019.1693266. Epub 2019 Nov 19.
Expert Rev Mol Diagn. 2019.
PMID: 31718325
Item in Clipboard
Cite
Cite